Mosharef Hossain Bhuiyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mosharef Hossain Bhuiyan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Emranul Kabir
University of Chittagong
3 shared publications - Mahbub Alam
Department of Chemistry, Bangladesh Army University of Science and Technology Khulna, Khulna 9204, Bangladesh
2 shared publications - Mohammed Mahbubul Matin
University of Chittagong
2 shared publications - Monir Uzzaman
Department of Applied Chemistry, Graduate School of Engineering, Mie University, Tsu, Mie 514-8507, Japan
2 shared publications - Abul Fazal Muhammad Sanaullah
University of Chittagong
1 shared publication - Ajoy Kumer
Department of Chemistry IUBAT‐International University of Business Agriculture & Technology Dhaka Bangladesh
1 shared publication
Latest Publications
- 30 October 2026
- Published by SAGE Publications in Main Group Chemistry
Synthesis, characterization, molecular docking, dynamics simulation and pharmacokinetic evaluation of some novel monosaccharide esters
The development of carbohydrate-derived bioactive scaffolds with adjustable molecular and pharmacological properties is a key goal in medicinal and pharmaceutical chemistry. In this study, two novel acylated monosaccharide derivatives e.g., compound 2 (Methyl 4,6- O -benzylidene-2,3-di- O -octanoyl-α - D-glucopyranoside) and compound 4 (Methyl 2,3- O -isopropylidene-5- O -valeroyl-β - D-ribofuranoside), were synthesized and characterized. Their antibacterial and antifungal properties were evaluated, revealing strain-dependent antimicrobial activity, though generally lower than reference agents. Compound 4 had the strongest antibacterial effect against Bacillus cereus , while compound 2 was more effective against Salmonella Typhi . Additionally, compound 2 exhibited the highest inhibition against Candida albicans , whereas compound 4 being most effective against Aspergillus niger . Molecular docking studies of synthesized esters against lanosterol 14α-demethylase (CYP51) and E. coli rhomboid protease GlpG showed that compound 2 had the most favorable docking score against CYP51 (−8.71 kcal/mol), while molecular dynamics simulations indicated stable behavior, supported by RMSD, RMSF, SASA, and radius of gyration (Rg) analyses. MM-GBSA calculations showed strong binding free energies (ΔG bind ≈ −81.36 kcal/mol and −46.65 kcal/mol for compound 2 and 4 respectively). The molecular dynamics simulations confirmed the structural stability and favorable interactions of compound 2 with target proteins e.g., lanosterol-14α-demethylase (PDB: 3LD6). ADMET and PASS analyses indicated compound-specific pharmacokinetic and biological profiles, highlighting potential issues for further study. These results demonstrate structure-dependent relationships among molecular architecture, antimicrobial activity, target recognition, dynamic behavior, and pharmacokinetics, offering a foundation for optimizing monosaccharide-derived bioactive scaffolds.
- 30 October 2026
- Published by SAGE Publications in Main Group Chemistry
Synthesis, characterization, molecular docking, dynamics simulation and pharmacokinetic evaluation of some novel monosaccharide esters
The development of carbohydrate-derived bioactive scaffolds with adjustable molecular and pharmacological properties is a key goal in medicinal and pharmaceutical chemistry. In this study, two novel acylated monosaccharide derivatives e.g., compound 2 (Methyl 4,6- O -benzylidene-2,3-di- O -octanoyl-α - D-glucopyranoside) and compound 4 (Methyl 2,3- O -isopropylidene-5- O -valeroyl-β - D-ribofuranoside), were synthesized and characterized. Their antibacterial and antifungal properties were evaluated, revealing strain-dependent antimicrobial activity, though generally lower than reference agents. Compound 4 had the strongest antibacterial effect against Bacillus cereus , while compound 2 was more effective against Salmonella Typhi . Additionally, compound 2 exhibited the highest inhibition against Candida albicans , whereas compound 4 being most effective against Aspergillus niger . Molecular docking studies of synthesized esters against lanosterol 14α-demethylase (CYP51) and E. coli rhomboid protease GlpG showed that compound 2 had the most favorable docking score against CYP51 (−8.71 kcal/mol), while molecular dynamics simulations indicated stable behavior, supported by RMSD, RMSF, SASA, and radius of gyration (Rg) analyses. MM-GBSA calculations showed strong binding free energies (ΔG bind ≈ −81.36 kcal/mol and −46.65 kcal/mol for compound 2 and 4 respectively). The molecular dynamics simulations confirmed the structural stability and favorable interactions of compound 2 with target proteins e.g., lanosterol-14α-demethylase (PDB: 3LD6). ADMET and PASS analyses indicated compound-specific pharmacokinetic and biological profiles, highlighting potential issues for further study. These results demonstrate structure-dependent relationships among molecular architecture, antimicrobial activity, target recognition, dynamic behavior, and pharmacokinetics, offering a foundation for optimizing monosaccharide-derived bioactive scaffolds.
- 27 May 2026
- Published by SAGE Publications in Main Group Chemistry
Antibacterial evaluation, quantum chemical computation, and pharmacological studies of some arylidenemalononitrile and ethyl 2-cyano-3-phenylacrylate derivatives: In vitro and in silico approach
The study emphasizes the importance of Knoevenagel condensation for forming carbon—carbon bonds to create biologically active α, β -unsaturated compounds. In this research, arylidenemalononitriles (AMN) ( 1–4 ) and ethyl 2-cyano-3-phenylacrylates (ECPA) ( 5–7 ) analogs were used to test the antibacterial efficacy against five human pathogens. Most of the compounds exhibited moderate to low inhibitory activity, whereas compounds 2 and 6 showed significant antibacterial effects, notably surpassing ampicillin in efficacy against Bacillus cereus and Escherichia coli. Molecular docking studies revealed strong binding affinities for these compounds ( 1–7 ) with bacterial proteins i.e., 1AH7 (−6.9 kcal/mol to −8.6 kcal/mol) and 6DR3 (−5.8 kcal/mol to −7.7 kcal/mol) respectively, indicating effective ligand–protein interactions. Structural analysis highlighted that specific functional groups showed enhance binding affinity, while PASS and ADMET predictions suggested favorable biological profiles for all compounds. The findings were corroborated by molecular dynamics simulations via NMA analyses and quantum chemical calculations, demonstrating strong agreement between experimental and computational results.
- 27 May 2026
- Published by SAGE Publications in Main Group Chemistry
Antibacterial evaluation, quantum chemical computation, and pharmacological studies of some arylidenemalononitrile and ethyl 2-cyano-3-phenylacrylate derivatives: In vitro and in silico approach
The study emphasizes the importance of Knoevenagel condensation for forming carbon—carbon bonds to create biologically active α, β -unsaturated compounds. In this research, arylidenemalononitriles (AMN) ( 1–4 ) and ethyl 2-cyano-3-phenylacrylates (ECPA) ( 5–7 ) analogs were used to test the antibacterial efficacy against five human pathogens. Most of the compounds exhibited moderate to low inhibitory activity, whereas compounds 2 and 6 showed significant antibacterial effects, notably surpassing ampicillin in efficacy against Bacillus cereus and Escherichia coli. Molecular docking studies revealed strong binding affinities for these compounds ( 1–7 ) with bacterial proteins i.e., 1AH7 (−6.9 kcal/mol to −8.6 kcal/mol) and 6DR3 (−5.8 kcal/mol to −7.7 kcal/mol) respectively, indicating effective ligand–protein interactions. Structural analysis highlighted that specific functional groups showed enhance binding affinity, while PASS and ADMET predictions suggested favorable biological profiles for all compounds. The findings were corroborated by molecular dynamics simulations via NMA analyses and quantum chemical calculations, demonstrating strong agreement between experimental and computational results.
- Open Access
- 17 March 2026
- Published by Elsevier in Aspects of Molecular Medicine
- Vol. 7
Synthesis, characterization, antimicrobial evaluation, pharmacokinetic and QSAR studies of some novel acrylates: in vitro and in silico approach
- 17 March 2026
- Published by Elsevier in Aspects of Molecular Medicine
- Vol. 7
Open AccessSynthesis, characterization, antimicrobial evaluation, pharmacokinetic and QSAR studies of some novel acrylates: in vitro and in silico approach
- 30 September 2022
- Published by ACG Publications in Organic Communications
- Vol. 15 (3) , 239-260
Antibacterial, antifungal and antiviral activities of pyrimido[4,5-d]pyrimidine derivatives through computational approaches
Pyrimido[4,5-d]pyrimidine conveys antimicrobial activity against various micro pathogens having functionalized properties. As a result, this study has designed to illustrate the antibacterial, antifungal, and antiviral properties of pyrimido[4,5-d]pyrimidine. First of all, these structures have been optimized from the characterization of synthesis for calculating chemical descriptors by DFT. Next, the auto docking and target docking against 12 proteins, such as Pseudomonas aeruginosa (2Y0H), Bacillus cereus (1AH7), Escherichia coli (6DR3), Shigella dysenteriae (3FHH) Salmonella typhi (3FHU), Aspergillus niger (1ACZ), Aspergillus flavus (1XY3), Rhizomucor miehei (4WTP), Candida auris (6U8J), three proteins of SARS-CoV-2 (7T9J, 7T9L, and 7TB4) were performed for the determination of binding sites and binding affinity. One FDA approved drug (Ampicillin) has docked against 12 proteins while the Bacillus cereus (Bacteria), Aspergillus flavus (Fungus), and SARS-CoV-2, 7T9L (Omicron) are obtained the best binding affinity after docking. The most common residues are the PHE-66, ARG-176 and VAL-124 for Bacillus cereus, Aspergillus flavus and SARS-CoV-2, Omicron (7T9L), respectively, as they blocked the active sites by the ligands as inhibitors. It is revealed that this study contained both auto docking and target docking whereas the binding affinity of auto docking is that the binding affinity for auto docking is higher than target docking. Finally, among the nine compounds, three compounds show outstanding results against bacteria, fungus and virus. At last, molecular dynamics were performed to check the stability and validation of the docked complex and quantum calculations obtained the molecular properties, as well as ADMET, pharmacokinetics, Lipinski Rule and QSAR data.
- 30 September 2022
- Published by ACG Publications in Organic Communications
- Vol. 15 (3) , 239-260
Antibacterial, antifungal and antiviral activities of pyrimido[4,5-d]pyrimidine derivatives through computational approaches
Pyrimido[4,5-d]pyrimidine conveys antimicrobial activity against various micro pathogens having functionalized properties. As a result, this study has designed to illustrate the antibacterial, antifungal, and antiviral properties of pyrimido[4,5-d]pyrimidine. First of all, these structures have been optimized from the characterization of synthesis for calculating chemical descriptors by DFT. Next, the auto docking and target docking against 12 proteins, such as Pseudomonas aeruginosa (2Y0H), Bacillus cereus (1AH7), Escherichia coli (6DR3), Shigella dysenteriae (3FHH) Salmonella typhi (3FHU), Aspergillus niger (1ACZ), Aspergillus flavus (1XY3), Rhizomucor miehei (4WTP), Candida auris (6U8J), three proteins of SARS-CoV-2 (7T9J, 7T9L, and 7TB4) were performed for the determination of binding sites and binding affinity. One FDA approved drug (Ampicillin) has docked against 12 proteins while the Bacillus cereus (Bacteria), Aspergillus flavus (Fungus), and SARS-CoV-2, 7T9L (Omicron) are obtained the best binding affinity after docking. The most common residues are the PHE-66, ARG-176 and VAL-124 for Bacillus cereus, Aspergillus flavus and SARS-CoV-2, Omicron (7T9L), respectively, as they blocked the active sites by the ligands as inhibitors. It is revealed that this study contained both auto docking and target docking whereas the binding affinity of auto docking is that the binding affinity for auto docking is higher than target docking. Finally, among the nine compounds, three compounds show outstanding results against bacteria, fungus and virus. At last, molecular dynamics were performed to check the stability and validation of the docked complex and quantum calculations obtained the molecular properties, as well as ADMET, pharmacokinetics, Lipinski Rule and QSAR data.
- Open Access
- 30 November 2021
- Published by The Turkish Chemical Society in Journal of the Turkish Chemical Society Section A: Chemistry
- Vol. 8 (4) , 1003-1024
Synthesis, and Spectral Characterization of 6-O-Octanoyl-1,2-O-isopropylidene-α-D-glucofuranose Derivatives
Site selective acylation of monosaccharides and oligosaccharides are very necessary for the preparation of both natural and novel synthetic carbohydrate compounds, synthetic intermediates, postglycosylation modifications, and for the preparation of therapeutic agents including research tools for glycobiology. Hence, site selective octanoylation of 1,2-O-isopropylidene-α-D-glucofuranose was conducted. Under low temperature in anhydrous pyridine direct unimolar octanoylation of this glucofuranose without any catalyst exhibited selectivity at C-6 hydroxyl group. The C-6 O-octanoylglucofuranose, thus obtained, was then used for the preparation of three 3,5-di-O-acyl esters in a similar direct method to get novel esters of glucofuranose. Characterization of all the glucofuranose esters by 1D and 2D spectroscopic technique is also discussed herein.
- 30 November 2021
- Published by The Turkish Chemical Society in Journal of the Turkish Chemical Society Section A: Chemistry
- Vol. 8 (4) , 1003-1024
Open AccessSynthesis, and Spectral Characterization of 6-O-Octanoyl-1,2-O-isopropylidene-α-D-glucofuranose Derivatives
Site selective acylation of monosaccharides and oligosaccharides are very necessary for the preparation of both natural and novel synthetic carbohydrate compounds, synthetic intermediates, postglycosylation modifications, and for the preparation of therapeutic agents including research tools for glycobiology. Hence, site selective octanoylation of 1,2-O-isopropylidene-α-D-glucofuranose was conducted. Under low temperature in anhydrous pyridine direct unimolar octanoylation of this glucofuranose without any catalyst exhibited selectivity at C-6 hydroxyl group. The C-6 O-octanoylglucofuranose, thus obtained, was then used for the preparation of three 3,5-di-O-acyl esters in a similar direct method to get novel esters of glucofuranose. Characterization of all the glucofuranose esters by 1D and 2D spectroscopic technique is also discussed herein.